Voyager Therapeutics
Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders.
All edits
April 13, 2015
On April 13, 2015 Voyager Therapeutics closed their series B funding round with $60 million in funding from Wellington Management, Partner Fund Management, Fidelity Management and Research Company, Casdin Capital, and Brookside Capital.
February 11, 2015
On February 11, 2015 Voyager Therapeutics announced they raised $30 million in their corporate funding round from Genzyme.
On February 11, 2015 Voyager Therapeutics announced they raised $30 million in their corporate funding round from Genzyme.
On April 13, 2015 Voyager Therapeutics closed their series B funding round with $60 million in funding from Wellington Management, Partner Fund Management, Fidelity Management and Research Company, Casdin Capital, and Brookside Capital.
Find more companies like Voyager Therapeutics
